Page last updated: 2024-08-26

10-hydroxycamptothecin and Carcinoma, Non-Small Cell Lung

10-hydroxycamptothecin has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hong, T; Li, J; Liu, W; Luo, J; Tong, L; Wang, F; Yan, L; Yang, X; Zhou, Y1

Other Studies

1 other study(ies) available for 10-hydroxycamptothecin and Carcinoma, Non-Small Cell Lung

ArticleYear
Astragalus polysaccharide combined with 10-hydroxycamptothecin inhibits metastasis in non-small cell lung carcinoma cell lines via the MAP4K3/mTOR signaling pathway.
    International journal of molecular medicine, 2018, Volume: 42, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Astragalus Plant; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Survival; Gene Expression; Humans; Lung Neoplasms; Mitochondria; Polysaccharides; Protein Serine-Threonine Kinases; Signal Transduction; TOR Serine-Threonine Kinases

2018